In leukemias, deregulated IRAK signaling has been reported in activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) [33, 46, 47]. This evidence concerns the gene IRAK1 and acute myeloid leukemia.